Literature DB >> 19229475

Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients.

Iacopo Cancelli1, Massimiliano Beltrame, Gian Luigi Gigli, Mariarosaria Valente.   

Abstract

Drug consumption in older people is usually high and many prescribed medications have unsuspected anticholinergic (ACH) (Table 1) properties. Drug induced ACH side-effects are particularly severe in aging brain and even more in demented patients. This review will focus on the association between ACH drug intake and the risk of developing central nervous system side-effects in elderly people. The threat of developing cognitive impairment, psychosis and delirium will be particularly analyzed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229475     DOI: 10.1007/s10072-009-0033-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  54 in total

Review 1.  Drug-induced cognitive impairment in the elderly.

Authors:  A R Moore; S T O'Keeffe
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Anticholinergic Model For Delirium.

Authors: 
Journal:  Semin Clin Neuropsychiatry       Date:  1996-10

3.  Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium.

Authors:  L Tune; S Carr; E Hoag; T Cooper
Journal:  Am J Psychiatry       Date:  1992-10       Impact factor: 18.112

4.  Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients.

Authors:  L Han; J McCusker; M Cole; M Abrahamowicz; F Primeau; M Elie
Journal:  Arch Intern Med       Date:  2001-04-23

5.  Delirium risk factors in elderly hospitalized patients.

Authors:  M Elie; M G Cole; F J Primeau; F Bellavance
Journal:  J Gen Intern Med       Date:  1998-03       Impact factor: 5.128

6.  Psychotic disorder induced by oxybutynin: Presentation of two cases.

Authors:  Murat Gulsun; Murat Pinar; Unal Sabanci
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

7.  The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?

Authors:  Ryan M Carnahan; Brian C Lund; Paul J Perry; Elizabeth A Chrischilles
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study.

Authors:  Iacopo Cancelli; Gian Luigi Gigli; Antonella Piani; Barbara Zanchettin; Francesco Janes; Adriana Rinaldi; Mariarosaria Valente
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

10.  Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.

Authors:  T Sunderland; P N Tariot; R M Cohen; H Weingartner; E A Mueller; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1987-05
View more
  30 in total

1.  [Drug interactions].

Authors:  V Hafner; B Grün; C Markert; D Czock; G Mikus; W E Haefeli
Journal:  Internist (Berl)       Date:  2010-03       Impact factor: 0.743

2.  Proton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.

Authors:  Jeffrey R Yager; Vincent A Magnotta; James A Mills; Stacie M Vik; Michelle T Weckmann; Aristides A Capizzano; Roger Gingrich; Leigh J Beglinger
Journal:  Psychiatry Res       Date:  2011-01-11       Impact factor: 3.222

3.  Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013.

Authors:  Maria Gustafsson; Per-Olof Sandman; Stig Karlsson; Ulf Isaksson; Jörn Schneede; Maria Sjölander; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2015-02-26       Impact factor: 2.953

4.  Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis.

Authors:  Jonny Olsson; Asa Bergman; Anders Carlsten; Thimothy Oké; Cecilia Bernsten; Ingrid K Schmidt; Johan Fastbom
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  Resident-Level Predictors of Dementia Pharmacotherapy at Long-Term Care Admission: The Impact of Different Drug Reimbursement Policies in Ontario and Saskatchewan: Prédicteurs de la pharmacothérapie de la démence au niveau des résidents lors de l'hospitalisation dans des soins de longue durée : l'impact de différentes politiques de remboursement des médicaments en Ontario et en Saskatchewan.

Authors:  Laura C Maclagan; Susan E Bronskill; Michael A Campitelli; Shenzhen Yao; Christoffer Dharma; David B Hogan; Nathan Herrmann; Joseph E Amuah; Colleen J Maxwell
Journal:  Can J Psychiatry       Date:  2020-04-10       Impact factor: 4.356

6.  Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients.

Authors:  Sermin Toto; Gudrun Hefner; Martina Hahn; Christoph Hiemke; Sibylle C Roll; Jan Wolff; Ansgar Klimke
Journal:  J Neural Transm (Vienna)       Date:  2021-01-13       Impact factor: 3.575

7.  Relationship between anticholinergic drug use and one-year outcome among elderly people hospitalised in medical wards via emergency department: the SAFES cohort study.

Authors:  D Narbey; D Jolly; R Mahmoudi; T Trenque; F Blanchard; J-L Novella; M Dramé
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

8.  Capturing side-effect of medication to identify persons at risk of delirium.

Authors:  Fulvio Lauretani; Gian Paolo Ceda; Marcello Maggio; Anna Nardelli; Marsilio Saccavini; Luigi Ferrucci
Journal:  Aging Clin Exp Res       Date:  2010 Oct-Dec       Impact factor: 3.636

9.  Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.

Authors:  Xiaolin Zhang; Shuang Zhou; Xinran Li; Weiwei Zhou; Ying Zhou; Yimin Cui; Xinmin Liu
Journal:  Int J Clin Pharm       Date:  2019-08-07

10.  Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophrenia.

Authors:  Julie Eve Desmarais; Linda Beauclair; Lawrence Annable; Marie-Claire Bélanger; Theodore T Kolivakis; Howard C Margolese
Journal:  Ther Adv Psychopharmacol       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.